Update
Optimapharm continues global expansion with new offices in the UK
In a string of expansion announcements, the Croatia-based CRO Optimapharm is now opening new offices in Cambridge, UK.
Archives for July 24, 2018
ObvioHealth creates new app for site-less clinical studies
The digital health startup ObvioHealth has launched a new mobile clinical study platform to streamline patient recruitment, reporting, and post-marketing surveillance.
Anima Biotech signs $1.05bn discovery and development deal with Lilly
Anima Biotech is eligible to receive up to $1.05bn as part of a multi-year drug discovery and development agreement with Lilly.
Akorn hit with another Form 483 at troubled Decatur site
The US FDA flagged inadequate cleaning and disinfecting systems in the Form 483, the third for Akorn, Inc. in two years.
Milk-derived drug delivery system given Roche backing
Roche has teamed up with PureTech to take advantage of its milk-derived exosome platform to potentially create oral formulations of antisense drugs.
WuXi STA and Antengene partner under MAH scheme
Antengene has selected CMO WuXi STA to develop and manufacture its mTOR inhibitor product ATG-008 for Chinese and Asia-Pacific markets.